08/10/2026 | Press release | Distributed by Public on 08/10/2026 13:52
The market sold a raised outlook, then bought part of it back a session later, and the disagreement is about memory prices and counter-drone hardware.
Axon Enterprise (AXON) shares rose 9.3% on Friday, one session after a 14.3% fall on the company's second-quarter 2026 results. Both days were trading the same set of numbers. Thursday's tape read the margin squeeze in that report as a warning; Friday's read it as the price of the growth the company had just guided higher, and the second reading has the better of the argument.
Photo by AlLes on PixabayThe Same Quarter Sold On Thursday And Bought On Friday
On the top line, the report reads well: revenue up 35% year over year to $904 million, a 10th consecutive quarter of growth above 30%, and a raised full-year outlook. The market's first verdict went the other way, on a gross margin that compressed in the software and services segment, weighed down by a higher mix of less lucrative professional services. Friday took back only part of that verdict, because a 9.3% gain does not undo a 14.3% fall. Getting back to even always costs more than the fall took away, which is the arithmetic the Trefis High Quality Portfolio is built around. Peers offer little cover: over the same Friday session CDRE fell 6.3%, MSI fell 1.4% and TYL, the strongest of the three peers, gained 2.0%, while the S&P 500 rose 0.6%, so this was about Axon, not about public safety budgets.
Memory Costs And Counter-Drone Hardware Are Doing The Squeezing
The company has named both forces itself. Component costs are climbing, memory especially, and Axon expects the Q3 adjusted EBITDA margin to carry that with none of the tariff refund that helped the second quarter, then to rebuild in Q4 so the full-year figure still lands 25.5%. The other force is mix. The counter-drone line the company runs as Dedrone passed $100 million in quarterly revenue and drove much of a 123% jump in Platform Solutions revenue. Those newer offerings are still scaling, which is what works against the overall margin. By management's own account the order is deliberate: the big upfront hardware sales come first, and the software gets built on the back of them. Axon Evidence remains the backbone of that software business.
The Third Quarter Is Where Thursday's Fear Gets Settled
So which session was right? Friday's, but only provisionally. Axon raised its 2026 revenue growth guidance to a range of 32% to 34% and left the full-year adjusted EBITDA margin outlook unchanged, which says the extra revenue is expected to arrive without extra margin. That is a reasonable trade if the hardware shipping now pulls software behind it, and a poor one if the memory bill proves permanent. Q3 is the first report that separates the two. At roughly a third below its 52-week high, the stock is not trading as though that question is closed. Until that report lands, the wider view worth having is which companies are actually raising their outlooks rather than defending them.
Growth This Fast Reprices Fast, Too
Axon may well be worth the patience while the software catches up with the hardware, but a company growing at this rate can lose a seventh of its value in one session and take only part of it back in the next. Spreading that timing risk across a rules-based portfolio is a different exercise from riding one name through it. That portfolio has a track record of outpacing the three major indices - the S&P 500, S&P Mid-cap, and Russell 2000.